Jan Van Elslande

InstitutionUniversity Hospitals Leuven
AddressLeuven
Belgium
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in October 2020
    All Publications
    Bar chart showing 9 publications over 3 distinct years, with a maximum of 5 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Van Elslande J, Gruwier L, Godderis L, Vermeersch P. Estimated Half-Life of SARS-CoV-2 Anti-Spike Antibodies More Than Double the Half-Life of Anti-nucleocapsid Antibodies in Healthcare Workers. Clin Infect Dis. 2021 12 16; 73(12):2366-2368. PMID: 33693643.
      Citations: 5     Fields:    Translation:Humans
    2. Van Elslande J, Vermeersch P, Vandervoort K, Wawina-Bokalanga T, Vanmechelen B, Wollants E, Laenen L, André E, Van Ranst M, Lagrou K, Maes P. Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain. Clin Infect Dis. 2021 07 15; 73(2):354-356. PMID: 32887979.
      Citations: 87     Fields:    Translation:Humans
    3. Van Elslande J, Oyaert M, Ailliet S, Van Ranst M, Lorent N, Vande Weygaerde Y, André E, Lagrou K, Vandendriessche S, Vermeersch P. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J Clin Virol. 2021 03; 136:104765. PMID: 33636554.
      Citations: 10     Fields:    Translation:HumansCells
    4. Van Elslande J, André E, Van Ranst M, Lagrou K, Vermeersch P. Immunoassays for anti-SARS-CoV-2 antibodies: recent insights. Lancet Infect Dis. 2021 05; 21(5):e120. PMID: 33137289.
      Citations: 3     Fields:    Translation:Humans
    5. Buntinx F, Claes P, Gulikers M, Verbakel J, Jan L, Van der Elst M, Van Elslande J, Van Ranst M, Vermeersch P. Added value of anti-SARS-CoV-2 antibody testing in a Flemish nursing home during an acute COVID-19 outbreak in April 2020. Acta Clin Belg. 2020 Oct 18; 1-6. PMID: 33070766.
      Citations: 5     Fields:    
    6. Decru B, Van Elslande J, Weemaes M, Houben E, Empsen I, André E, Van Ranst M, Lagrou K, Vermeersch P. Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2. Clin Chem Lab Med. 2020 09 25; 58(10):e197-e199. PMID: 32628628.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    7. Weemaes M, Martens S, Cuypers L, Van Elslande J, Hoet K, Welkenhuysen J, Goossens R, Wouters S, Houben E, Jeuris K, Laenen L, Bruyninckx K, Beuselinck K, André E, Depypere M, Desmet S, Lagrou K, Van Ranst M, Verdonck AKLC, Goveia J. Laboratory information system requirements to manage the COVID-19 pandemic: A report from the Belgian national reference testing center. J Am Med Inform Assoc. 2020 08 01; 27(8):1293-1299. PMID: 32348469.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    8. Van Elslande J, Decru B, Jonckheere S, Van Wijngaerden E, Houben E, Vandecandelaere P, Indevuyst C, Depypere M, Desmet S, André E, Van Ranst M, Lagrou K, Vermeersch P. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Clin Microbiol Infect. 2020 Nov; 26(11):1557.e1-1557.e7. PMID: 32745595.
      Citations: 46     Fields:    Translation:HumansCellsPHPublic Health